Capital Institute Of Pediatrics, China

This study tests finerenone, a drug that may reduce kidney inflammation and protein leakage, in children aged 3–17 with Henoch-Schönlein purpura nephritis and mild proteinuria. About 116 participants will receive finerenone to see if it lowers urine protein better than current st…